Anifrolumab-fnia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosus.

Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosus.

Journal: Lupus

Published: June 01, 2026

Discoid Lupus Erythematosus Successfully Treated With Anifrolumab.

Discoid Lupus Erythematosus Successfully Treated With Anifrolumab.

Journal: Cureus

Published: May 03, 2026

Comparing adverse events of Saphnelo and Benlysta: A real-world observational study based on the FDA adverse event reporting system (FAERS) following STROBE guidelines.

Comparing adverse events of Saphnelo and Benlysta: A real-world observational study based on the FDA adverse event reporting system (FAERS) following STROBE guidelines.

Journal: Medicine

Published: July 15, 2025

Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): an observational study protocol.

Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): an observational study protocol.

Journal: Lupus science & medicine

Published: December 20, 2024

Immunotherapeutic approaches for systemic lupus erythematosus: early overview and future potential.

Immunotherapeutic approaches for systemic lupus erythematosus: early overview and future potential.

Journal: Medical review (2021)

Published: July 20, 2023

Pharmacological actions of anifrolumab (Saphnelo®) and clinical trial results as a treatment for systemic lupus erythematosus

Pharmacological actions of anifrolumab (Saphnelo®) and clinical trial results as a treatment for systemic lupus erythematosus

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: July 05, 2022

Anifrolumab: First Approval.

Anifrolumab: First Approval.

Journal: Drugs

Published: September 23, 2021

Anifrolumab (Saphnelo) for systemic lupus erythematosus.

Anifrolumab (Saphnelo) for systemic lupus erythematosus.

Journal: The Medical letter on drugs and therapeutics

Published: September 22, 2021

Anifrolumab-fnia.

Anifrolumab-fnia.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Published: September 07, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026